Stocks in play: HLS Therapeutics Inc.
Will release its Q2 fiscal 2024 financial results on Thursday, August 8. The Company will hold a conference call that same day at 8:30 a.m. ET to discuss its results. HLS Therapeutics Inc. shares T.HLS are trading unchanged at $3.24.
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.